Oxaliplatin Accord

Oxaliplatin, the active ingredient in Oxaliplatin Accord, is a Alkylating agent presented as a presented for intravenous use. It treats colorectal cancer in adult patients.

GNH USA supplies Oxaliplatin Accord as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres worldwide.

Oxaliplatin Accord is  ​        ​  ...  ....  ...   ... ....  ...

{"the   ":null}